Reactive chemistry for covalent probe and therapeutic development.

Area of Science:

• Medicinal Chemistry
• Chemical Biology
• Drug Discovery

Background:

• Bioactive small molecules forming covalent bonds with target proteins are crucial for research and drug development.
• Covalent drugs offer high efficacy through a defined mechanism of action (MOA).

Purpose of the Study:

• To review reactive groups in thiophilic and oxophilic drugs that act via covalent MOA.
• To highlight advanced proteomic and bioanalytical methods for assessing covalent agent selectivity.
• To explore novel electrophiles for covalent probe and therapeutic development, including understudied protein residues.

Main Methods:

• Review of literature on covalent drugs and their reactive functional groups.
• Discussion of proteomic and bioanalytical techniques for selectivity profiling.
• Exploration of chemical strategies for targeting various amino acid residues.

Main Results:

• Identification of key reactive groups in thiophilic and oxophilic covalent drugs.
• Demonstration of advanced methodologies for evaluating selectivity of covalent inhibitors.
• Expansion of focus to include covalent modification of understudied amino acid residues.

Conclusions:

• Covalent drugs are valuable tools in research and medicine, with diverse reactive groups enabling targeted protein modification.
• Advanced analytical techniques are essential for guiding the development of selective covalent agents.
• Further exploration of understudied residues offers new avenues for covalent drug discovery.